Cancer Research PRL Inhibitor Induces the Cleavage of p130Cas  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 41, 463-466, February 1, 1981]
© 1981 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Curry, R. A.
Right arrow Articles by Ferrone, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Curry, R. A.
Right arrow Articles by Ferrone, S.

Lysis of Cultured Human Melanoma M10 Cells by Polyclonal Xenoantibodies to Melanoma-associated Antigens1

Russell A. Curry, Vito Quaranta2, Michele A. Pellegrino3 and Soldano Ferrone4

Department of Molecular Immunology, Scripps Clinic and Research Foundation, La Jolla, California 92037

Cultured human melanoma cells M10 harvested from cultures in different phases of their growth show significant changes in the expression of melanoma-associated antigens (MAA), but they do not vary in susceptibility to lysis mediated by anti-MAA xenoantisera and effected by complement or lymphoid cells. Furthermore, melanoma cells M10 showed a significant increase in susceptibility to immune lysis following treatment with puromycin at doses that do not effect the expression of MAA. The lack of correlation between MAA density and susceptibility to immune lysis supports the contention that, under the experimental conditions used, cellular properties play a major role in the outcome of immune attack.

1 Supported by USPHS Grants Al 13154, CA 16069, and CA 16071. This is Publication 1794 from Scripps Clinic and Research Foundation.

2 Fellow of the Leukemia Society of America.

3 Recipient of a Research Career Development Award from the National Cancer Institute.

4 Recipient of an American Heart Association Established Investigatorship Award. To whom requests for reprints should be addressed.

Received 12/10/79. Accepted 11/ 4/80.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1981 by the American Association for Cancer Research.